News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

Tech Pioneer Awarded to Manchester Entrepreneur

Jul 5th 2024
Dr. Farid Khan, CEO of PharmaKure was awarded Asian Tech Pioneer in his work in Biotech.
Read More

PharmaKure granted MHRA Clinical Trial Authorisation (CTA) for PK051 for the tre...

Jan 5th 2024
Clinical Trial Authorisation application granted for combined drug PK051 targeting amyloid deposits associated with Alzheimer’s Disease
Read More

PharmaKure submits MHRA CTA for Phase 2a Clinical Trial of PK051 in patients wit...

Oct 24th 2023
PharmaKure submits MHRA CTA for Phase 2a Clinical Trial of PK051 in patients with mild cognitive impairment Clinical Trial Application filed for combined drug targeting amyloid deposits as...
Read More

PharmaKure announces study success for novel blood test to identify biomarkers i...

Oct 17th 2023
Study confirms ALZmetrixTM whole blood test can detect people at high risk of developing full Alzheimer’s Disease
Read More

World Alzheimer's Day- using AI to diagnose early stages of the disease

Sep 21st 2023
Stopping memory loss: how to use AI to diagnose and treat dementia early.
Read More

PharmaKure and APIS Assay Technologies Sign a Collaboration for the Development ...

Jul 3rd 2023
PharmaKure, a company specialising in companion diagnostics for the treatment of neurological diseases and APIS Assay Technologies Ltd, a company with scientific expertise in biomarker trans...
Read More

PharmaKure Announces Successful Scientific Advice Meeting with the MHRA

Feb 6th 2023
With approval of MHRA to submit a CTA, PharmaKure is now well positioned to advance towards its clinical trial programme that is essential to market authorisation
Read More

PharmaKure has launched a study to identify blood-based biomarkers in patients w...

Oct 4th 2022
PharmaKure has launched a study to examine the relationship between blood biomarkers and historical PET scans or CSF in patients with Mild Cognitive Impairment due to Alzheimer’s Disease.
Read More

Alzheimer’s disease: Modeling current and potential targets

Aug 14th 2019
By the time we are 65, one in ten of us will have contracted Alzheimer’s disease. Currently there are only four FDA approved drugs for the alleviation of the symptoms of Alzheimer’s dise...
Read More

Search Site

  Latest Jobs

Sign up to our Newsletter

Our Valued Sponsors & Partners